oxaliplatin
oxaliplatin is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including oxaliplatin, Oxaliplatin, OXALIPLATIN. Available dosage forms: powder, injection, solution, injection, solution, concentrate.
Drug Details
- Generic Name
- oxaliplatin
- Brand Names
- oxaliplatin, Oxaliplatin, OXALIPLATIN
- Application Number
- ANDA203869
- Sponsor
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- NDC Codes
- 11
- Dosage Forms
- POWDER, INJECTION, SOLUTION, INJECTION, SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- OXALIPLATIN
Indications and Usage
1 INDICATIONS AND USAGE Oxaliplatin Injection USP, in combination with infusional fluorouracil and leucovorin, is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. treatment of advanced colorectal cancer. Oxaliplatin Injection USP is a platinum-based drug used in combination with infusional fluorouracil and leucovorin, which is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. ( 1 ) treatment of advanced colorectal cancer. ( 1 )